Friday, March 20, 2020 1:09:54 PM
IMO Hydroxychloroquine will be a part of the initial clinical trials. The clinical trials of approved drugs is essential to evaluate which treatment is the most efficacious. These trials will be streamlined and relatively quick. They will be performed in a controlled fashion so efficacy can be compared between the agents.
As I mentioned in an earlier post combining agents will also be done soon:
I look for the secondary trials to combine hydroxychloroquine with the second tier drugs which are approved or close to approval such as :Antivirals like Remdisvir, antibiotic antiinflammatory Brilacidin, antiinflammatory tocilizumab.
It is possible triple drug combinations similar to some HIV treatments may prove optimal.
GLTA, Farrell
FEATURED Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • Mar 16, 2026 8:37 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
